[Generalized Castleman's disease associated with Kaposi's sarcoma].
Reverter
J C
JC
Nomdedeu
B
B
Martín Ortega
E
E
Llebaría
C
C
Palou
J
J
Rozman
C
C
D005871:Castleman Disease / Q000150:complications* / Q000188:drug therapy; D003520:Cyclophosphamide / Q000009:adverse effects* / Q000627:therapeutic use; D005534:Foot Diseases / Q000150:complications*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007890:Leiomyosarcoma; D008297:Male; D008875:Middle Aged; D009378:Neoplasms, Multiple Primary; D011379:Prognosis; D012514:Sarcoma, Kaposi / Q000150:complications*
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide
Enfermedad de Castleman generalizada asociada a sarcoma de Kaposi.